ATE184649T1 - Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen - Google Patents
Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzenInfo
- Publication number
- ATE184649T1 ATE184649T1 AT95913981T AT95913981T ATE184649T1 AT E184649 T1 ATE184649 T1 AT E184649T1 AT 95913981 T AT95913981 T AT 95913981T AT 95913981 T AT95913981 T AT 95913981T AT E184649 T1 ATE184649 T1 AT E184649T1
- Authority
- AT
- Austria
- Prior art keywords
- cleavage
- rna
- egs
- targeted
- rnaase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/126—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes involving RNAse P
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/207,547 US5624824A (en) | 1989-03-24 | 1994-03-07 | Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence |
| US08/215,082 US5728521A (en) | 1989-03-24 | 1994-03-18 | Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE184649T1 true ATE184649T1 (de) | 1999-10-15 |
Family
ID=26902350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95913981T ATE184649T1 (de) | 1994-03-07 | 1995-03-07 | Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5869248A (de) |
| EP (1) | EP0748383B1 (de) |
| JP (1) | JPH10508181A (de) |
| AT (1) | ATE184649T1 (de) |
| AU (1) | AU696138B2 (de) |
| CA (1) | CA2185117A1 (de) |
| DE (1) | DE69512219T2 (de) |
| WO (1) | WO1995024489A1 (de) |
Families Citing this family (117)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869248A (en) * | 1994-03-07 | 1999-02-09 | Yale University | Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| US6057153A (en) * | 1995-01-13 | 2000-05-02 | Yale University | Stabilized external guide sequences |
| US5683873A (en) * | 1995-01-13 | 1997-11-04 | Innovir Laboratories, Inc. | EGS-mediated inactivation of target RNA |
| US5877162A (en) * | 1996-03-14 | 1999-03-02 | Innovir Laboratories, Inc. | Short external guide sequences |
| AU4071197A (en) * | 1996-08-16 | 1998-03-06 | Yale University | Phenotypic conversion of drug-resistant bacteria to drug-sensitivity |
| US6610478B1 (en) | 1996-08-16 | 2003-08-26 | Yale University | Phenotypic conversion of cells mediated by external guide sequences |
| US6013447A (en) * | 1997-11-21 | 2000-01-11 | Innovir Laboratories, Inc. | Random intracellular method for obtaining optimally active nucleic acid molecules |
| US6248525B1 (en) | 1998-03-30 | 2001-06-19 | Yale University | Method for identifying essential or functional genes |
| GB9912965D0 (en) * | 1999-06-03 | 1999-08-04 | Oxford Biomedica Ltd | In vivo selection method |
| US8293224B2 (en) * | 2000-02-07 | 2012-10-23 | Trustees Of Dartmouth College | Attenuated uracil auxotroph of an apicomplexan and use thereof |
| JP2003534789A (ja) * | 2000-05-31 | 2003-11-25 | イスティトゥート ディ バイオロジア チェルラーレ,シーエヌアール | Rna切断方法 |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| JP5305553B2 (ja) | 2000-10-12 | 2013-10-02 | ユニバーシティー オブ ロチェスター | 癌細胞の増殖を阻害する組成物 |
| EP1572168B1 (de) | 2002-02-06 | 2010-05-26 | Vicor Technologies, Inc. | Anti-infarkt-moleküle |
| EP1534729A2 (de) * | 2002-02-26 | 2005-06-01 | University of Utah Research Foundation | Mit bluthochdruck und virusknospung assoziierte nedd4l-varianten |
| US7858367B2 (en) * | 2002-04-30 | 2010-12-28 | Duke University | Viral vectors and methods for producing and using the same |
| US20030215872A1 (en) * | 2002-05-20 | 2003-11-20 | Clark-Mxr, Inc. | Screening apparatus and method for making |
| US20030215815A1 (en) * | 2002-05-20 | 2003-11-20 | Clark William G. | Screening method |
| US20050287648A1 (en) | 2002-08-05 | 2005-12-29 | University Of Rochester | Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
| US8512701B2 (en) | 2002-11-15 | 2013-08-20 | Morehouse School Of Medicine | Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration |
| US8658377B2 (en) | 2002-11-15 | 2014-02-25 | Morehouse School Of Medicine | Detecting cancer with anti-CCL25 and anti-CCR9 antibodies |
| US9233120B2 (en) | 2002-11-15 | 2016-01-12 | Jyant Technologies | Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration |
| CN1780920B (zh) * | 2003-05-12 | 2012-03-28 | 波多玛克制药有限公司 | 基因表达抑制剂 |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| CA2564988A1 (en) * | 2004-04-29 | 2005-10-29 | Yale University | Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| EP2551282A3 (de) | 2005-03-23 | 2013-02-13 | Genmab A/S | Antikörper gegen CD38 zur Behandling von multiplem Myelom |
| US7476733B2 (en) * | 2005-03-25 | 2009-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease |
| JP4911915B2 (ja) | 2005-05-09 | 2012-04-04 | トヨタ自動車株式会社 | 標的物の分解方法及び分解装置 |
| AU2006302245A1 (en) * | 2005-10-06 | 2007-04-19 | Emthrax, Llc | Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| EP2395076A1 (de) | 2005-10-14 | 2011-12-14 | MUSC Foundation For Research Development | Targeting von PAX2 zur Induktion der DEFB1-vermittelten Tumorimmunität und Krebstherapie |
| US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
| WO2007084773A2 (en) * | 2006-01-20 | 2007-07-26 | University Of North Carolina At Chapel Hill | Enhanced production of infectious parvovirus vectors in insect cells |
| EP1998792B1 (de) | 2006-03-01 | 2015-02-18 | The University of Utah Research Foundation | Verfahren und zusammensetzungen in verbindung mit der synthese zyklischer peptide |
| US8470965B2 (en) | 2006-03-01 | 2013-06-25 | University Of Utah Research Foundation | Methods and compositions related to cyclic peptide synthesis |
| EP2066812A4 (de) | 2006-09-21 | 2010-04-28 | Univ Rochester | Zusammensetzungen und verfahren in zusammenhang mit proteinverschiebungstherapie für myotone dystrophie |
| WO2008136852A2 (en) | 2006-11-01 | 2008-11-13 | University Of Rochester | Methods and compositions related to the structure and function of apobec3g |
| JP2010512327A (ja) * | 2006-12-11 | 2010-04-22 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | 病的血管形成および脈管透過性の処置用の組成物および方法 |
| US9896511B2 (en) | 2007-01-10 | 2018-02-20 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies |
| US9493817B2 (en) | 2007-03-05 | 2016-11-15 | Genesis Research Institute, Inc. | Decomposition method and decomposition apparatus for nucleic acid polymer |
| WO2009026496A1 (en) * | 2007-08-22 | 2009-02-26 | University Of Southern California | Grp78 and tumor angiogenesis |
| AU2008296487A1 (en) | 2007-08-28 | 2009-03-12 | The Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| JP2010538005A (ja) * | 2007-08-28 | 2010-12-09 | ユーエービー リサーチ ファウンデーション | 合成アポリポ蛋白質e模倣ポリペプチドおよび使用方法 |
| WO2010070380A2 (en) * | 2007-12-03 | 2010-06-24 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health | Doc1 compositions and methods for treating cancer |
| US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
| US9241898B2 (en) | 2008-03-11 | 2016-01-26 | Yale University | Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| US9822364B2 (en) | 2008-03-11 | 2017-11-21 | Yale University | Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| JP2011517410A (ja) * | 2008-04-08 | 2011-06-09 | アミリス バイオテクノロジーズ, インコーポレイテッド | 異種配列の発現 |
| US20110262395A1 (en) | 2008-05-08 | 2011-10-27 | University Of Utah Research Foundation | Sensory receptors for chronic fatigue and pain and uses thereof |
| US20120070443A1 (en) | 2008-12-02 | 2012-03-22 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
| US20110318738A1 (en) | 2008-12-23 | 2011-12-29 | University Of Utah Research Foundation | Identification and regulation of a novel dna demethylase system |
| EP2396343B1 (de) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modifizierte virusvektoren sowie verfahren zu ihrer herstellung und verwendung |
| US20120077753A1 (en) | 2009-06-25 | 2012-03-29 | Laxman Gangwani | Jnk inhibitors for use in treating spinal muscular atrophy |
| WO2011031974A1 (en) | 2009-09-10 | 2011-03-17 | Southern Research Institute | Acridine analogs in the treatment of gliomas |
| WO2011060065A2 (en) | 2009-11-10 | 2011-05-19 | Lipella Pharmaceuticals Inc. | Instillation of liposomal formulation of sirna and antisense oligonucleotides |
| US8889615B2 (en) | 2009-12-31 | 2014-11-18 | New York University | Methods for promoting epithelialization and healing of chronic wounds |
| US9169494B2 (en) | 2010-01-12 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
| WO2012056441A1 (en) * | 2010-10-28 | 2012-05-03 | Nanodoc Ltd. | Compositions and methods for specific cleavage of exogenous rna in a cell |
| JP2014505239A (ja) | 2010-12-14 | 2014-02-27 | モアハウス スクール オブ メディスン | 癌の治療または検出のための抗cxcl13および抗cxcr5抗体の使用 |
| CA2826273C (en) | 2011-02-10 | 2021-11-02 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| AU2012259312A1 (en) | 2011-05-20 | 2013-12-12 | Government Of The United States, As Represented By The Secretary Department Of Health And Human Services | Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof |
| WO2013044116A1 (en) | 2011-09-21 | 2013-03-28 | Yale University | Antimicrobial compositions and methods of use thereof |
| CN102568437B (zh) | 2012-01-20 | 2014-07-30 | 华为终端有限公司 | 图像显示方法及设备 |
| PL2900686T3 (pl) | 2012-09-28 | 2021-01-25 | The University Of North Carolina At Chapel Hill | Wektory aav ukierunkowane na oligodendrocyty |
| EP2970966A4 (de) | 2013-03-15 | 2016-10-26 | Univ North Carolina | Synthetische adenoassoziierte virusinvertierte endwiederholungssequenzen |
| ES2926774T3 (es) | 2013-03-15 | 2022-10-28 | Univ North Carolina Chapel Hill | Métodos y composiciones para vectores AAV de doble unión de glicano |
| JP7081923B2 (ja) | 2014-07-31 | 2022-06-07 | ユーエイビー リサーチ ファンデーション | アポe模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果 |
| AU2015339447B2 (en) | 2014-10-27 | 2021-08-12 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for natural killer cells |
| AU2015349759B2 (en) | 2014-11-21 | 2022-01-06 | The University Of North Carolina At Chapel Hill | Aav vectors targeted to the central nervous system |
| AU2016206624B2 (en) | 2015-01-14 | 2020-08-06 | The University Of North Carolina At Chapel Hill | Methods and compositions for targeted gene transfer |
| KR102554850B1 (ko) | 2015-02-06 | 2023-07-13 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도 |
| WO2016134300A1 (en) | 2015-02-20 | 2016-08-25 | Board Of Regents, The University Of Texas System | Methods and compositions for attenuated chlamydia as vaccine and vector |
| US10723794B2 (en) | 2015-03-18 | 2020-07-28 | University Of South Carolina | Anti-CcL8 antibodies and uses thereof |
| IL314171A (en) | 2015-09-28 | 2024-09-01 | Univ Florida | Methods and compositions for antibody-evading virus vectors |
| US11124546B2 (en) | 2015-12-14 | 2021-09-21 | The University Of North Carolina At Chapel Hill | Modified capsid proteins for enhanced delivery of parvovirus vectors |
| EP3449250B1 (de) | 2016-04-28 | 2020-11-04 | Indiana University Research & Technology Corporation | Verfahren und zusammensetzungen zur auflösung von komponenten einer viruspräparation |
| EP3496736A4 (de) | 2016-08-03 | 2020-05-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Gegen tlr9 gerichtete therapeutika |
| ES2978159T3 (es) | 2016-09-16 | 2024-09-06 | Hsf Pharmaceuticals | Inhibidores de factores de choque térmico (HSF) y usos de los mismos |
| WO2018170310A1 (en) | 2017-03-15 | 2018-09-20 | The University Of North Carolina At Chapel Hill | Polyploid adeno-associated virus vectors and methods of making and using the same |
| WO2019051355A1 (en) | 2017-09-08 | 2019-03-14 | Ohio State Innovation Foundation | NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
| US11668719B2 (en) | 2017-09-20 | 2023-06-06 | The Trustees Of Indiana University | Methods for resolving lipoproteins with mass spectrometry |
| US11232941B2 (en) | 2018-01-12 | 2022-01-25 | The Trustees Of Indiana University | Electrostatic linear ion trap design for charge detection mass spectrometry |
| CA3092107A1 (en) | 2018-02-28 | 2019-09-06 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
| MX2020010465A (es) | 2018-04-03 | 2021-01-08 | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| BR112020020266A2 (pt) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | Vetores de vírus com evasão de anticorpos |
| CA3095179A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
| WO2019236143A1 (en) | 2018-06-04 | 2019-12-12 | The Trustees Of Indiana University | Apparatus and method for calibrating or resetting a charge detector |
| KR102742958B1 (ko) | 2018-06-04 | 2024-12-16 | 더 트러스티즈 오브 인디애나 유니버시티 | 실시간 분석 및 신호 최적화를 통한 전하 검출 질량 분광분석법 |
| WO2019236141A1 (en) | 2018-06-04 | 2019-12-12 | The Trustees Of Indiana University | Apparatus and method for capturing ions in an electrostatic linear ion trap |
| WO2019236139A1 (en) | 2018-06-04 | 2019-12-12 | The Trustees Of Indiana University | Interface for transporting ions from an atmospheric pressure environment to a low pressure environment |
| US11227759B2 (en) | 2018-06-04 | 2022-01-18 | The Trustees Of Indiana University | Ion trap array for high throughput charge detection mass spectrometry |
| JP7428664B2 (ja) | 2018-06-12 | 2024-02-06 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 合成肝臓指向性アデノ随伴ウイルスカプシドおよびその使用 |
| CN112639110A (zh) | 2018-06-22 | 2021-04-09 | 阿斯克肋匹奥生物制药公司 | 用于基因递送以在细胞内持续存在的载体 |
| KR20210100086A (ko) | 2018-10-04 | 2021-08-13 | 유니버시티 오브 로체스터 | 혈장 오스몰농도 조작에 의한 글림프 전달의 개선 |
| CN113574632B (zh) | 2018-11-20 | 2024-07-30 | 印地安纳大学理事会 | 用于单粒子质谱分析的轨道阱 |
| AU2019392058B2 (en) | 2018-12-03 | 2024-12-05 | The Trustees Of Indiana University | Apparatus and method for simultaneously analyzing multiple ions with an electrostatic linear ion trap |
| CN113727992A (zh) | 2019-03-21 | 2021-11-30 | 斯特里迪比奥公司 | 重组腺相关病毒载体 |
| WO2020219527A1 (en) | 2019-04-23 | 2020-10-29 | The Trustees Of Indiana University | Identification of sample subspecies based on particle charge behavior under structural change-inducing sample conditions |
| AU2020263392A1 (en) | 2019-04-26 | 2021-10-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding AAV2.5 vector |
| US12112936B2 (en) | 2019-09-25 | 2024-10-08 | The Trustees Of Indiana University | Apparatus and method for pulsed mode charge detection mass spectrometry |
| JP7659325B2 (ja) | 2019-10-10 | 2025-04-09 | ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー | 粒子を識別、選択、および純化するためのシステムおよび方法 |
| CN114787180A (zh) | 2019-10-17 | 2022-07-22 | 斯特里迪比奥公司 | 用于治疗c型尼曼-匹克病的腺相关病毒载体 |
| MX2022004353A (es) | 2019-10-17 | 2022-07-19 | Casete de transferencia de aav. | |
| JP7690209B2 (ja) | 2019-12-18 | 2025-06-10 | ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー | 電荷測定装置を有する質量分析計 |
| KR102923996B1 (ko) | 2020-02-03 | 2026-02-05 | 더 트러스티즈 오브 인디애나 유니버시티 | 전하 검출 질량 분석법을 위한 신호들의 시간-도메인 분석 |
| CA3177268A1 (en) | 2020-05-05 | 2021-11-11 | The University Of North Carolina At Chapel Hill | Modified adeno-associated virus 5 capsids and uses thereof |
| JP2023542614A (ja) | 2020-08-19 | 2023-10-11 | サレプタ セラピューティクス, インコーポレイテッド | レット症候群の治療のためのアデノ随伴ウイルスベクター |
| CN116490514A (zh) | 2020-10-28 | 2023-07-25 | 北卡罗来纳-查佩尔山大学 | 用于双重聚糖结合aav2.5载体的方法和组合物 |
| TW202242124A (zh) | 2021-01-14 | 2022-11-01 | 美商史崔德生物公司 | 靶向t細胞之aav載體 |
| JP2024515626A (ja) | 2021-04-16 | 2024-04-10 | アスクレピオス バイオファーマシューティカル, インコーポレイテッド | 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドaavビリオン |
| US12492245B2 (en) | 2021-09-21 | 2025-12-09 | University Of South Carolina | Anti-CCL8 antibodies and treatment of lung injury by CCL8 inhibition |
| JP2025504263A (ja) | 2021-12-23 | 2025-02-10 | ユニバーシティ オブ ロチェスター | 内耳への薬剤の送達のためのcsf輸送経路 |
| JP2025503508A (ja) | 2021-12-23 | 2025-02-04 | ユニバーシティ オブ ロチェスター | 内耳への薬剤の送達のための組成物及び方法 |
| TW202342759A (zh) | 2022-02-04 | 2023-11-01 | 美商史崔德生物公司 | 重組腺相關病毒載體及其使用方法 |
| WO2024040222A1 (en) | 2022-08-19 | 2024-02-22 | Generation Bio Co. | Cleavable closed-ended dna (cedna) and methods of use thereof |
| WO2024124019A2 (en) | 2022-12-07 | 2024-06-13 | Ginkgo Bioworks, Inc. | Aav vectors targeting hematopoietic stem cells |
| WO2026085495A1 (en) | 2024-10-18 | 2026-04-23 | Generation Bio Co. | Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3681787D1 (de) * | 1985-07-05 | 1991-11-07 | Whitehead Biomedical Inst | Expression von fremdem genetischem material in epithelzellen. |
| US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| US4987071A (en) * | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| GB2213684A (en) * | 1987-12-11 | 1989-08-16 | Philips Electronic Associated | Data demodulator baud clock phase locking |
| ATE115999T1 (de) * | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
| DE68927996T2 (de) * | 1988-02-05 | 1997-12-04 | Hughes Howard Med Inst | Modifizierte hepatozyten und deren anwendung |
| DE68929306T2 (de) * | 1988-04-27 | 2002-05-02 | Isis Pharmaceutical, Inc. | H-Phosphonat Ribonucleotid-Derivate |
| AU4315689A (en) * | 1988-08-16 | 1990-03-23 | Fox Chase Cancer Center | Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders |
| WO1990002806A1 (en) * | 1988-09-01 | 1990-03-22 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
| US5624824A (en) * | 1989-03-24 | 1997-04-29 | Yale University | Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence |
| US5168053A (en) * | 1989-03-24 | 1992-12-01 | Yale University | Cleavage of targeted RNA by RNAase P |
| US5225347A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Therapeutic ribozyme compositions and expression vectors |
| US5225337A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
| JPH05506993A (ja) * | 1990-04-20 | 1993-10-14 | ザ・ジェネラル・ホスピタル・コーポレーション | ウイルスの複製を防止する方法 |
| ES2061243T3 (es) * | 1990-05-07 | 1994-12-01 | Anchor Hocking Packaging | Un cierre compuesto para sellar y resellar un recipiente. |
| DE4216134A1 (de) * | 1991-06-20 | 1992-12-24 | Europ Lab Molekularbiolog | Synthetische katalytische oligonukleotidstrukturen |
| AU659482B2 (en) * | 1991-06-28 | 1995-05-18 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
| US5525719A (en) * | 1991-08-30 | 1996-06-11 | Chemgenes Corporation | N-protected-2'-O-methyl-and N-protected-3'-O-methyl-ribonucleosides and their phosphoramidite derivatives |
| JP3015463B2 (ja) * | 1992-04-28 | 2000-03-06 | エール ユニバーシティ | 真核リボヌクレアーゼpを用いるrnaの標的化切断および外部ガイド配列 |
| JPH08507203A (ja) * | 1992-12-04 | 1996-08-06 | イノーバー ラボラトリーズ,インコーポレイテッド | 調節可能な核酸治療およびそれらの使用方法 |
| ATE217347T1 (de) * | 1992-12-04 | 2002-05-15 | Univ Yale | Diagnose mittels signalverstärkung durch ein ribozym |
| IL108206A0 (en) * | 1993-01-06 | 1994-04-12 | Univ Johns Hopkins | Oligomers having improved stability at acid ph |
| US6012375A (en) * | 1993-07-06 | 2000-01-11 | Eckstein; Donald B. | Aircraft infrared guided defense missile system |
| AU706417B2 (en) * | 1994-02-23 | 1998-06-17 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting the expression of disease related genes |
| US5869248A (en) * | 1994-03-07 | 1999-02-09 | Yale University | Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| AU4961996A (en) * | 1994-12-14 | 1996-07-03 | Innovir Laboratories, Inc. | Ribozyme-mediated inactivation of leukemia-associated rna |
-
1994
- 1994-03-07 US US08/702,652 patent/US5869248A/en not_active Expired - Lifetime
- 1994-03-18 US US08/215,082 patent/US5728521A/en not_active Expired - Lifetime
-
1995
- 1995-03-07 WO PCT/US1995/002816 patent/WO1995024489A1/en not_active Ceased
- 1995-03-07 JP JP7523583A patent/JPH10508181A/ja not_active Ceased
- 1995-03-07 AU AU21165/95A patent/AU696138B2/en not_active Ceased
- 1995-03-07 EP EP95913981A patent/EP0748383B1/de not_active Expired - Lifetime
- 1995-03-07 AT AT95913981T patent/ATE184649T1/de not_active IP Right Cessation
- 1995-03-07 CA CA002185117A patent/CA2185117A1/en not_active Abandoned
- 1995-03-07 DE DE69512219T patent/DE69512219T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10508181A (ja) | 1998-08-18 |
| EP0748383A1 (de) | 1996-12-18 |
| US5728521A (en) | 1998-03-17 |
| AU696138B2 (en) | 1998-09-03 |
| DE69512219D1 (de) | 1999-10-21 |
| WO1995024489A1 (en) | 1995-09-14 |
| EP0748383B1 (de) | 1999-09-15 |
| US5869248A (en) | 1999-02-09 |
| CA2185117A1 (en) | 1995-09-14 |
| AU2116595A (en) | 1995-09-25 |
| DE69512219T2 (de) | 2000-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69512219D1 (de) | Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen | |
| GR3020859T3 (en) | Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence. | |
| ATE216705T1 (de) | Antisense-oligonukleotidmodulation der raf- genexpression | |
| ATE309378T1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
| AR245776A1 (es) | Metodo para la modificacion de las caracteristicas de expresion de un gen endogeno de un microorganismo o una linea celular determinada. | |
| DK1546174T3 (da) | Fremgangsmåder og sammensætninger til RNA-interferens | |
| ATE267866T1 (de) | Kurze externe führungssequenzen | |
| ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
| DE60144517D1 (de) | Rekombinante konstrukte und ihre verwendung bei der reduzierung der genexpression | |
| DE69403642D1 (de) | 7-deazapurin modifizierte oligonukleotide | |
| WO2004033620A3 (en) | Methods and compositions for therapeutic use of rna interference | |
| DK1123414T3 (da) | Antisense-modulering af integrin alpha 4.ekspression | |
| DK1175489T3 (da) | Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider | |
| DE69738753D1 (de) | AUF TGF-beta 1 ANSPRECHENDE KNOCHENMARKZELLEN | |
| BR0008788A (pt) | Sequencias anti-sentido antitumor dirigidas contra componentes r1 e r2 de ribonucleotìdeo reductase | |
| WO1999023216A3 (en) | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | |
| DK0843731T3 (da) | Adenovirusvektorer til genterapi | |
| ES8301503A1 (es) | Procedimiento para la produccion de un microorganismo gene- ticamente modificado | |
| EP1163373A4 (de) | Antisense-modulation des zellulären hemmstoffs der apoptosis-expression | |
| DE60130465D1 (de) | Mutierte muskelspezifische enhancer | |
| WO2003050247A3 (en) | Antisense modulation of mhc class ii transactivator expression | |
| Yuan et al. | Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence | |
| DE60131973D1 (de) | Regulation der upa gen-expression durch methylierte nukleotide | |
| ATE359372T1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
| MXPA02002444A (es) | Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |